Psychiatry

Hepatology

Questions discussed in this category

Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?

2 Answers available

How do you manage fatty liver disease in patients on olanzapine who are reluctant to change meds?

I have several forensic patients who have elevated LFTs and fatty liver on ultrasound, at least in part due to long-term olanzapine use. They are all ...

2 Answers available

Papers discussed in this category

Drug and alcohol dependence, 2024 Sep 07

Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.

JAMA psychiatry, 2025 Apr 01

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial.

The New England journal of medicine, 2024 Jul 25

Dual Agonists for Management of Metabolic Dysfunction-Associated Steatohepatitis.

Psychiatry

Hepatology

Questions discussed in this category

Papers discussed in this category

Related Topics in Psychiatry